Estimation of content of anti-TB drugs supplied at centres of the Revised National TB Control Programme in Tamil Nadu, India

Author:

Ramachandran Geetha1,Chandrasekaran Vedachalam1,Hemanth Kumar Agibothu Kupparam1,Dewan Puneet2,Swaminathan Soumya1,Thomas Aleyamma1

Affiliation:

1. National Institute for Research in Tuberculosis (Indian Council of Medical Research); Chennai India

2. Bill and Melinda Gates Foundation; New Delhi India

Funder

MDP

USAID

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Parasitology

Reference16 articles.

1. Quality control of anti-tuberculosis fixed-dose combination formulations in the global market: an in vitro study;Ashokraj;The International Journal of Tuberculosis and Lung Disease,2004

2. Pilot study of essential drug quality in two major cities in India;Bate;PLoS ONE,2009

3. Substandard and falsified anti-tuberculosis drugs: a preliminary field analysis;Bate;The International Journal of Tuberculosis and Lung Disease,2013

4. Host factors and chemotherapy of tuberculosis. In: Barry VC ed. Chemotherapy of tuberculosis, London, Butterworths, p 175. Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence;Canetti;Journal of Antimicrobial Chemotherapy,2007

5. Substandard medicines in resource-poor settings: a problem that can no longer be ignored;Caudron;Tropical Medicine & International Health,2008

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3